Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
the intersection of computer science and drug research, to support strategic focus on the use of AI in scientific research within the general area related to drug security. The position is at
-
Cancer Clinical Research Facility (Cancer CRF, jointly developed with University College Hospital), and the CR-UK/UCL Clinical Trials Centre (CTC). TRACERx is a UK-wide lung cancer evolution programme
-
of the Quadram Early Career Fellowship programme are for the successful candidates to: • Initiate an independent research programme at QIB to generate preliminary data in support of fellowship applications
-
creative Postdoctoral Fellow to join our multidisciplinary team dedicated to investigating the causes and consequences of somatic mutations in cancer. Our lab integrates cutting-edge computational and
-
research clinicians concerned with both basic immunological principles and understanding the immune response through treatment. The post holder will be based within the largest CAR T cell program in Europe
-
of immune cells as key regulators of the tumor microenvironment. Collaboration with pathologists for tissue imaging correlations and with computational biologists is expected. The work will largely involve
-
at the intersection of psychology and biology, who thrive in interdisciplinary research environments! Disciplines Biomedicine, life science, health science, psychology, computing Application The application should be
-
AI for the benefit of society, and also includes a significant investment in computing infrastructure along with 6 senior professorial posts. The AI+ Academic Fellowships aim to attract the brightest
-
, life sciences, computational sciences, behavioral sciences, or engineering by October 1, 2025. Applicants who intend to defend their dissertation after October 1, 2025, are not eligible. May not be
-
College Hospital), and the CR-UK/UCL Clinical Trials Centre (CTC). TRACERx is a UK-wide lung cancer evolution programme which started in 2014 and has to date recruited over 820 patients. It is the first